This paper considers how best to achieve patient and public involvement in research and how to get the most out of it http://ow.ly/R0hwV.
Four respiratory medicine disease categories appear in the global top 10 causes of mortality , resulting in 600 000 people dying from respiratory disease in Europe each year. The economic burden of respiratory diseases in Europe exceeds 380 billion euros. In a fast-developing environment, new clinical challenges have arisen for pulmonary specialists;… (More)
Lymphangioleiomyomatosis (LAM) is a rare lung disease that almost exclusively affects women and develops in about one in 400 000 adult females. The European Lung Foundation worked closely with one of the patient organisations within its network, the European LAM Federation, to raise awareness of LAM at the 2014 European Respiratory Society International… (More)
This study aimed to gain insight into the impact of lung conditions on smoking behaviour and smoking cessation, and identify recommendations for smoking cessation and professional-patient communications. The study was led by the European Lung Foundation in collaboration with the European Respiratory Society Task Force on "Statement on smoking cessation on… (More)
ERS/ELF say "take the active option" for Healthy Lungs for Life http://ow.ly/R1WaX.
Patients are included, welcomed and integrated at the ERS International Congress http://ow.ly/UpV8A.